On 23 May 2019, the National Medical Products Administration ("NMPA") issued the "Action Plan for Accelerating Drug Smart Supervision (GUO YAO JIAN ZONG 2019, No.26)" ("Drug Smart Supervision Plan"), aiming to deepen the development of a drug supervision system embracing modern information technologies such as cloud computing, big data, and "Internet+" technologies.
Even before the Drug Smart Supervision Plan was issued, some provincial...
June 20, 2019
5 min read